Patents by Inventor Ashok V. Katdare

Ashok V. Katdare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compressed tablet formulation
    Patent number: 7595063
    Abstract: This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: September 29, 2009
    Assignee: Merck & Co., Inc.
    Inventors: Udit Batra, Raymond J. Higgins, Karen C. Thompson, Ashok V. Katdare
  • Compressed tablet formulation
    Patent number: 7060294
    Abstract: This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: June 13, 2006
    Inventors: Udit Batra, Raymond J. Higgins, Karen C. Thompson, Ashok V. Katdare
  • Wet granulation formulation for bisphosphonic acids
    Publication number: 20040137056
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by wet granulation tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease. These compositions are prepared without the addition of binder; instead, the drug itself acts as a binder.
    Type: Application
    Filed: December 19, 2003
    Publication date: July 15, 2004
    Inventors: Ashok V. Katdare, Kenneth A. Kramer
  • Effervescent bisphosphonate formulation
    Publication number: 20040137058
    Abstract: An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and optionally, flavoring agents, colorants and sweeteners.
    Type: Application
    Filed: January 5, 2004
    Publication date: July 15, 2004
    Inventors: Ashok V. Katdare, Kenneth A. Kramer, Colin R. Gardner
  • Wet granulation formulation for bisphosphonic acids
    Patent number: 6692764
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by wet granulation tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease. These compositions are prepared without the addition of binder; instead, the drug itself acts as a binder.
    Type: Grant
    Filed: September 23, 2002
    Date of Patent: February 17, 2004
    Assignee: Merck & Co., Inc.
    Inventors: Ashok V. Katdare, Kenneth A. Kramer
  • Dry granulation formulation for an HIV protease inhibitor
    Patent number: 6645961
    Abstract: This invention relates to a dry granulation capsule formulation of the HIV protease inhibitor, indinavir sulfate, which is useful in the treatment of AIDS, ARC or HIV infection. Processes for making the oral formulation are also disclosed.
    Type: Grant
    Filed: March 4, 1998
    Date of Patent: November 11, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Chung Y. Lui, Drazen Ostovic, Ashok V. Katdare, Christine Stelmach
  • Pharmaceutical tablets
    Patent number: 6623755
    Abstract: The present invention relates to novel pharmaceutical tablets useful for administering pharmaceutical active ingredients, such as bisphosphonates. These tablets have improved surface properties which can aid esophageal transit, thereby reducing the potential for adverse gesture intestinal effects. The present invention also relates to processes for making said novel pharmaceutical tablets.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: September 23, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Tzyy-Show H. Chen, Thomas G. Nyairo, Ashok V. Katdare
  • Wet granulation formulation for bisphosphonic acids
    Publication number: 20030032628
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by wet granulation tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease. These compositions are prepared without the addition of binder; instead, the drug itself acts as a binder.
    Type: Application
    Filed: September 23, 2002
    Publication date: February 13, 2003
    Applicant: Merck & Co., Inc.
    Inventors: Ashok V. Katdare, Kenneth A. Kramer
  • Dry mix formulation for bisphosphonic acids
    Patent number: 6517867
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: February 11, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Simon R. Bechard, Kenneth A. Kramer, Ashok V. Katdare
  • Effer-vescent bisphosphonate formulation
    Publication number: 20030003147
    Abstract: An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and optionally, flavoring agents, colorants and sweeteners.
    Type: Application
    Filed: July 9, 2002
    Publication date: January 2, 2003
    Applicant: Merck & Co., Inc.
    Inventors: Ashok V. Katdare, Colin R. Gardner, Kenneth A. Kramer
  • Pharmaceutical tablets
    Publication number: 20020187186
    Abstract: The present invention relates to novel pharmaceutical tablets useful for administering pharmaceutical active ingredients, such as bisphosphonates. These tablets have improved surface properties which can aid esophageal transit, thereby reducing the potential for adverse gesture intestinal effects. The present invention also relates to processes for making said novel pharmaceutical tablets.
    Type: Application
    Filed: March 15, 2002
    Publication date: December 12, 2002
    Applicant: Merck & Co., Inc.
    Inventors: Tzyy-Show H. Chen, Thomas G. Nyairo, Ashok V. Katdare
  • Wet granulation formulation for bisphosphonic acids
    Publication number: 20020137727
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by wet granulation tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease. These compositions are prepared without the addition of binder; instead, the drug itself acts as a binder.
    Type: Application
    Filed: March 4, 2002
    Publication date: September 26, 2002
    Applicant: Merck & Co., Inc.
    Inventors: Ashok V. Katdare, Kenneth A. Kramer
  • Compressed tablet formulation
    Publication number: 20020076436
    Abstract: This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.
    Type: Application
    Filed: June 28, 2001
    Publication date: June 20, 2002
    Inventors: Udit Batra, Raymond J. Higgins, Karen C. Thompson, Ashok V. Katdare
  • Dry mix formulation for bisphosphonic acids
    Patent number: 6406714
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: June 18, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Simon R. Bechard, Kenneth A. Kramer, Ashok V. Katdare
  • Dry mix formulation for bisphosphonic acids
    Publication number: 20020054906
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
    Type: Application
    Filed: October 19, 2001
    Publication date: May 9, 2002
    Applicant: MERCK & Co., Inc.
    Inventors: Simon R. Bechard, Kenneth A. Kramer, Ashok V. Katdare
  • Effervescent bisphosphonate formulation
    Publication number: 20010041165
    Abstract: An effervescent formulation of alendronate contains an acid source, a carbonate source, a binder, a lubricant and optionally, flavoring agents, colorants and sweeteners.
    Type: Application
    Filed: June 11, 2001
    Publication date: November 15, 2001
    Applicant: MERCK & CO., Inc.
    Inventors: Ashok V. Katdare, Colin R. Gardner, Kenneth A. Kramer
  • Pharmaceutical tablets
    Publication number: 20010036475
    Abstract: The present invention relates to novel pharmaceutical tablets useful for administering pharmaceutical active ingredients, such as bisphosphonates. These tablets have improved surface properties which can aid esophageal transit, thereby reducing the potential for adverse gesture intestinal effects. The present invention also relates to processes for making said novel pharmaceutical tablets.
    Type: Application
    Filed: June 14, 2001
    Publication date: November 1, 2001
    Applicant: MERCK & CO., Inc.
    Inventors: Tzyy-Show H. Chen, Thomas G. Nyairo, Ashok V. Katdare
  • COMPRESSED TABLET FORMULATION
    Publication number: 20010014352
    Abstract: This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.
    Type: Application
    Filed: May 17, 1999
    Publication date: August 16, 2001
    Inventors: UDIT BATRA, RAYMOND J. HIGGINS, ASHOK V. KATDARE
  • Wet granulation formulation for bisphosphonic acids
    Publication number: 20010007863
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by wet granulation tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease. These compositions are prepared without the addition of binder; instead, the drug itself acts as a binder.
    Type: Application
    Filed: February 15, 2001
    Publication date: July 12, 2001
    Applicant: MERCK & CO., Inc.
    Inventors: Ashok V. Katdare, Kenneth A. Kramer
  • Dry mix formulation for bisphosphonic acids
    Patent number: 6194004
    Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
    Type: Grant
    Filed: November 2, 1999
    Date of Patent: February 27, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Simon R. Bechard, Kenneth A. Kramer, Ashok V. Katdare